SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
NOHO, Inc. (DRNK) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 30/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — DRNK
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2013 |
$-0.21 |
$545.87K |
$-2.75M |
-503.5% |
| 2014 |
$-0.27 |
$964.97K |
$-4.93M |
-511% |
| 2015 |
$-0.01 |
$625.21K |
$-1.32M |
-211% |
| 2016 |
$0.00 |
$0.00 |
$-962.2K |
- |
| 2019 |
$0.00 |
$0.00 |
$-107.66K |
- |
| 2020 |
$0.00 |
$0.00 |
$-239.47K |
- |
| 2021 |
$0.00 |
$159.07K |
$-68.25K |
-42.9% |
| 2022 |
$0.00 |
$78.8K |
$236.4K |
300% |
| 2024 |
$0.00 |
$25.33K |
$-243.56K |
-961.8% |
| 2025 |
$0.00 |
$0.00 |
$-241.45K |
- |
